Of note, the authors attempted to validate the specificity of IHC staining for these macrophages using flow cytometry with a variety of cell markers and reported a distinct cluster of GAMMs in the rGBM tumor, which were CD68+/CD11b+ in the tumor bulk and CD68+/CD163+ in the infiltrative margin of the tumor. The gene discussed is CD163; the disease is neoplasm.